Innovation1 Biotech Inc. (IVBT)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -620.19 Thousand | -3.12 Million | -30.4 Thousand | -410.24 Thousand | -775.92 Thousand | -442.56 Thousand |
| Net Income | -5.98 Million | -40.87 Million | 1.03 Million | -2.58 Million | -170.06 Thousand | -975.52 Thousand |
| Depreciation & Amortization | 52.69 Thousand | 138.26 Thousand | 1414.00 | 2613.00 | 1916.00 | 530.00 |
| Deferred income taxes | 3.3 Million | - | - | - | -520.66 Thousand | - |
| Stock-based compensation | 103 Thousand | - | - | - | 18.77 Thousand | 674.01 Thousand |
| Change in working capital | 1.27 Million | -432.59 Thousand | 257.02 Thousand | 702.46 Thousand | -156.49 Thousand | -5457.00 |
| Other non-cash items | 630.19 Thousand | 38.04 Million | -1.32 Million | 1.46 Million | 50.6 Thousand | -136.12 Thousand |
| Investing Cash Flow | - | -853.13 Thousand | - | -300 Thousand | -6564.00 | -2467.00 |
| Investments in PPE | -5.00 | -3138.00 | - | - | -6564.00 | -2467.00 |
| Acquisitions | - | -850 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -850 Thousand | - | -300 Thousand | -6564.00 | -2467.00 |
| Financing Cash Flow | 513.55 Thousand | 4 Million | 150 Thousand | 709.15 Thousand | 27 Thousand | 1.21 Million |
| Debt repayment | -513.55 Thousand | - | -150 Thousand | -38.84 Thousand | -27 Thousand | -49.5 Thousand |
| Dividends payments | - | - | -169.63 Thousand | - | -27.28 Thousand | - |
| Common Stock Repurchased | - | - | - | -80 Thousand | - | - |
| Common Stock Issuance | - | 4 Million | - | - | - | 160 Thousand |
| Other Financing Activities | 1.02 Million | 4000.00 | 319.63 Thousand | 828 Thousand | 81.28 Thousand | 1.05 Million |
| Accounts receivables | 48.52 Thousand | -56.42 Thousand | 132.85 Thousand | 67.14 Thousand | 428.00 | -428.00 |
| Accounts payables | -248.56 Thousand | -41.52 Thousand | 132.1 Thousand | 422.51 Thousand | -10.85 Thousand | 94.18 Thousand |
| Inventory | -48.52 Thousand | 56.42 Thousand | 1000.00 | 166.11 Thousand | -150.45 Thousand | -53.11 Thousand |
| Other working capital | 1.52 Million | -391.07 Thousand | -8924.00 | 46.68 Thousand | 4389.00 | -46.1 Thousand |
| Cash at beginning of period | 156.48 Thousand | 137.47 Thousand | 17.88 Thousand | 18.97 Thousand | 774.46 Thousand | 25.00 |
| Cash at end of period | 49.84 Thousand | 156.48 Thousand | 137.47 Thousand | 17.88 Thousand | 18.97 Thousand | 774.46 Thousand |
| Capital Expenditure | -5.00 | -3138.00 | - | - | -6564.00 | -2467.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -106.63 Thousand | 19.01 Thousand | 119.59 Thousand | -1094.00 | -755.49 Thousand | 774.44 Thousand |
| Free Cash Flow | -620.2 Thousand | -3.13 Million | -30.4 Thousand | -410.24 Thousand | -782.49 Thousand | -445.02 Thousand |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.45 Million | -5.98 Million | -298.85 Thousand | -298.85 Thousand | -603.38 Thousand | -40.87 Million |
| Depreciation & Amortization | 262.00 | 52.69 Thousand | 262.00 | 262.00 | 262.00 | 138.26 Thousand |
| Deferred income taxes | 38.47 Thousand | 3.3 Million | -19.23 Thousand | -19.23 Thousand | - | - |
| Stock-based compensation | -80.5 Thousand | 103 Thousand | 80.5 Thousand | - | - | - |
| Change in working capital | 838.96 Thousand | 1.27 Million | -40.43 Thousand | -40.43 Thousand | 92.63 Thousand | -432.59 Thousand |
| Other non-cash items | 3.58 Million | 630.19 Thousand | 88.45 Thousand | 88.45 Thousand | 301.71 Thousand | 38.04 Million |
| Investing Cash Flow | - | - | - | - | - | -853.13 Thousand |
| Investments in PPE | -5.00 | - | - | - | - | -3138.00 |
| Acquisitions | - | - | - | - | - | -850 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -850 Thousand |
| Financing Cash Flow | -677.11 Thousand | 513.55 Thousand | 213.55 Thousand | 213.55 Thousand | 250 Thousand | 4 Million |
| Debt repayment | -26.89 | -513.55 Thousand | -213.55 Thousand | -250 Thousand | -50 Thousand | - |
| Dividends payments | -187.57 Thousand | - | - | - | -187.57 Thousand | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 4 Million |
| Other Financing Activities | 26.89 | 1.02 Million | 213.55 Thousand | 463.55 Thousand | 487.57 Thousand | 4000.00 |
| Accounts receivables | 48.52 Thousand | 48.52 Thousand | - | - | - | -56.42 Thousand |
| Accounts payables | 43.36 Thousand | -248.56 Thousand | -25.1 Thousand | -25.1 Thousand | -316.76 Thousand | -41.52 Thousand |
| Inventory | -48.52 Thousand | -48.52 Thousand | - | - | - | 56.42 Thousand |
| Other working capital | 795.59 Thousand | 1.52 Million | -15.32 Thousand | -15.32 Thousand | 409.39 Thousand | -391.07 Thousand |
| Cash at beginning of period | 76.72 Thousand | 156.48 Thousand | 52.47 Thousand | 52.47 Thousand | 11.25 Thousand | 137.47 Thousand |
| Cash at end of period | 49.84 Thousand | 49.84 Thousand | 76.72 Thousand | 76.72 Thousand | 52.47 Thousand | 156.48 Thousand |
| Capital Expenditure | -5.00 | - | - | - | - | -3138.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -26.87 Thousand | -106.63 Thousand | 24.24 Thousand | 24.24 Thousand | 41.22 Thousand | 19.01 Thousand |
| Free Cash Flow | -26.88 Thousand | -620.19 Thousand | -189.31 Thousand | -189.31 Thousand | -208.77 Thousand | -3.13 Million |
WCW
1157
GMLA
FSPKF
0909
CFTLF